Birgit Girshick - 10 Jan 2024 Form 4/A Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A
Accepted by SEC
31 Jan 2024, 17:34:45 UTC
Original report date
11 Jan 2024
Prior SEC filing
31 May 2023
Next SEC filing
25 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Birgit Girshick

Key filing fact

Birgit Girshick filed Form 4/A for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 31 Jan 2024.

Key facts

  • This page summarizes Birgit Girshick's Form 4/A filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 31 Jan 2024, 17:34.

Change

  • Previous filing in this sequence was filed on 31 May 2023.
  • Current net transaction value: -$128,200.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Options Exercise

Transaction value
$855,868
Shares
+5,916
Change %
+13%
Price
$144.67
Shares after
50,365
Date
10 Jan 2024
Ownership
Direct
CRL transaction

Common Stock

Tax liability

Transaction value
$984,067
Shares
-4,617
Change %
-9.2%
Price
$213.14
Shares after
45,748
Date
10 Jan 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRL transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-5,916
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 Jan 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,916
Exercise price
$144.67
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The transaction was executed as a net exercise, in which no shares were purchased or sold in the open market.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .